Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 503068, 9 pages
http://dx.doi.org/10.1155/2011/503068
Review Article

Computational Vaccinology: An Important Strategy to Discover New Potential S. mansoni Vaccine Candidates

1Departamento de Bioquímica, Imunologia do Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil
2Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais (INCT-DT), CNPq MCT, 31270-901, BA, Brazil
3Departamento de Biologia Geral do Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil

Received 1 June 2011; Accepted 12 August 2011

Academic Editor: Anne S. De Groot

Copyright © 2011 Carina S. Pinheiro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. van der Werf, S. J. de Vlas, S. Brooker et al., “Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa,” Acta Tropica, vol. 86, no. 2-3, pp. 125–139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Steinmann, J. Keiser, R. Bos, M. Tanner, and J. Utzinger, “Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk,” The Lancet Infectious Diseases, vol. 6, no. 7, pp. 411–425, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. Harder, “Chemotherapeutic approaches to trematodes (except schistosomes) and cestodes: current level of knowledge and outlook,” Parasitology Research, vol. 88, no. 6, pp. 587–590, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. N. R. Bergquist and D. G. Colley, “Schistosomiasis vaccines: research to development,” Parasitology Today, vol. 14, no. 3, pp. 99–104, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. N. R. Bergquist, “Schistosomiasis: from risk assessment to control,” Trends in Parasitology, vol. 18, no. 7, pp. 309–314, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Chitsulo, P. Loverde, and D. Engels, “Schistosomiasis,” Nature Reviews, vol. 2, no. 1, pp. 12–13, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. S. Braschi, W. C. Borges, and R. A. Wilson, “Proteomic analysis of the shistosome tegument and its surface membranes,” Memorias do Instituto Oswaldo Cruz, vol. 101, supplement 1, pp. 205–212, 2006. View at Google Scholar · View at Scopus
  8. S. Braschi, R. S. Curwen, P. D. Ashton, S. Verjovski-Almeida, and A. Wilson, “The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction,” Proteomics, vol. 6, no. 5, pp. 1471–1482, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. Braschi and R. A. Wilson, “Proteins exposed at the adult schistosome surface revealed by biotinylation,” Molecular and Cellular Proteomics, vol. 5, no. 2, pp. 347–356, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. W. Castro-Borges, A. Dowle, R. S. Curwen, J. Thomas-Oates, and R. A. Wilson, “Enzymatic shaving of the tegument surface of live schistosomes for proteomic analysis: a rational approach to select vaccine candidates,” PLoS Neglected Tropical Diseases, vol. 5, no. 3, Article ID e993, 2011. View at Publisher · View at Google Scholar · View at PubMed
  11. S. Verjovski-Almeida, R. DeMarco, E. A. Martins et al., “Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni,” Nature Genetics, vol. 35, no. 2, pp. 148–157, 2003. View at Publisher · View at Google Scholar · View at PubMed
  12. M. Berriman, B. J. Haas, P. T. Loverde et al., “The genome of the blood fluke Schistosoma mansoni,” Nature, vol. 460, no. 7253, pp. 352–358, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. D. P. McManus and A. Loukas, “Current status of vaccines for schistosomiasis,” Clinical Microbiology Reviews, vol. 21, no. 1, pp. 225–242, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. R. Bergquist, J. Utzinger, and D. P. McManus, “Trick or treat: the role of vaccines in integrated schistosomiasis control,” PLoS Neglected Tropical Diseases, vol. 2, no. 6, article e244, 2008. View at Publisher · View at Google Scholar · View at PubMed
  15. M. Nielsen, C. Lundegaard, and O. Lund, “Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method,” BMC Bioinformatics, vol. 8, article 238, 2007. View at Publisher · View at Google Scholar · View at PubMed
  16. M. K. Jones, G. N. Gobert, L. Zhang, P. Sunderland, and D. P. McManus, “The cytoskeleton and motor proteins of human schistosomes and their roles in surface maintenance and host-parasite interactions,” BioEssays, vol. 26, no. 7, pp. 752–765, 2004. View at Publisher · View at Google Scholar · View at PubMed
  17. J. J. Van Hellemond, K. Retra, J. F. Brouwers et al., “Functions of the tegument of schistosomes: clues from the proteome and lipidome,” International Journal for Parasitology, vol. 36, no. 6, pp. 691–699, 2006. View at Publisher · View at Google Scholar · View at PubMed
  18. P. J. Hotez, J. M. Bethony, D. J. Diemert, M. Pearson, and A. Loukas, “Developing vaccines to combat hookworm infection and intestinal schistosomiasis,” Nature Reviews, vol. 8, no. 11, pp. 814–826, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. M. H. Tran, M. S. Pearson, J. M. Bethony et al., “Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis,” Nature Medicine, vol. 12, no. 7, pp. 835–840, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. F. C. Cardoso, G. C. Macedo, E. Gava et al., “Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection,” PLoS Neglected Tropical Diseases, vol. 2, no. 10, article e308, 2008. View at Publisher · View at Google Scholar · View at PubMed
  21. F. Liu, J. Lu, W. Hu et al., “New perspectives on host-parasite interplay by comparative transcriptomic and proteomic analyses of Schistosoma japonicum,” PLoS Pathogens, vol. 2, no. 4, pp. 268–281, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. S. Verjovski-Almeida and R. DeMarco, “Current developments on Schistosoma proteomics,” Acta Tropica, vol. 108, no. 2-3, pp. 183–185, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. A. D. Osterhaus, P. Koraka, and B. E. Martina, “Bioinformatics in new generation flavivirus vaccines,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 864029, 2010. View at Publisher · View at Google Scholar · View at PubMed
  24. R. A. Wilson, R. S. Curwen, S. Braschi, S. L. Hall, P. S. Coulson, and P. D. Ashton, “From genomes to vaccines via the proteome,” Memorias do Instituto Oswaldo Cruz, vol. 99, no. 5, pp. 45–50, 2004. View at Google Scholar · View at Scopus
  25. B. W. van Balkom, R. A. van Gestel, J. F. Brouwers et al., “Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome,” Journal of Proteome Research, vol. 4, no. 3, pp. 958–966, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. H. Rammensee, J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanović, “SYFPEITHI: database for MHC ligands and peptide motifs,” Immunogenetics, vol. 50, no. 3-4, pp. 213–219, 1999. View at Google Scholar · View at Scopus
  27. C. Kesmir, A. K. Nussbaum, H. Schild, V. Detours, and S. Brunak, “Prediction of proteasome cleavage motifs by neural networks,” Protein Engineering, vol. 15, no. 4, pp. 287–296, 2002. View at Google Scholar · View at Scopus
  28. E. Gasteiger, A. Gattiker, C. Hoogland, I. Ivanyi, R. D. Appel, and A. Bairoch, “ExPASy: the proteomics server for in-depth protein knowledge and analysis,” Nucleic Acids Research, vol. 31, no. 13, pp. 3784–3788, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. L. P. Farias, F. C. Cardoso, P. A. Miyasato et al., “Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection,” PLoS Neglected Tropical Diseases, vol. 4, no. 2, article e597, 2010. View at Publisher · View at Google Scholar · View at PubMed
  30. S. C. Oliveira, C. T. Fonseca, F. C. Cardoso, L. P. Farias, and L. C. Leite, “Recent advances in vaccine research against schistosomiasis in Brazil,” Acta Tropica, vol. 108, no. 2-3, pp. 256–262, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. G. Ahmad, W. Torben, W. Zhang, M. Wyatt, and A. A. Siddiqui, “Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni,” Parasite Immunology, vol. 31, no. 3, pp. 156–161, 2009. View at Publisher · View at Google Scholar · View at PubMed
  32. M. E. Hemler, “Specific tetraspanin functions,” The Journal of Cell Biology, vol. 155, no. 7, pp. 1103–1107, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. E. J. Nascimento, R. V. Amorim, A. Cavalcanti et al., “Assessment of a DNA vaccine encoding an anchored-glycosylphosphatidylinositol tegumental antigen complexed to protamine sulphate on immunoprotection against murine schistosomiasis,” Memorias do Instituto Oswaldo Cruz, vol. 102, no. 1, pp. 21–27, 2007. View at Google Scholar
  34. E. J. Pearce, A. I. Magee, S. R. Smithers, and A. J. G. Simpson, “Sm25, a major schistosome tegumental glycoprotein, is dependent on palmitic acid for membrane attachment,” The EMBO Journal, vol. 10, no. 10, pp. 2741–2746, 1991. View at Google Scholar
  35. M. M. Petzke, P. K. Suri, R. Bungiro et al., “Schistosoma mansoni gene GP22 encodes the tegumental antigen Sm25: (1) Antibodies to a predicted B-cell epitope of Sm25 cross-react with other candidate vaccine worm antigens; (2) characterization of a recombinant product containing tandem-repeats of this peptide as a vaccine,” Parasite Immunology, vol. 22, no. 8, pp. 381–395, 2000. View at Publisher · View at Google Scholar
  36. K. A. Shalaby, L. Yin, A. Thakur, L. Christen, E. G. Niles, and P. T. LoVerde, “Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes,” Vaccine, vol. 22, no. 1, pp. 130–136, 2003. View at Publisher · View at Google Scholar
  37. H. M. Ahmed and M. H. Romeih, “Protection against Schistosoma mansoni infection with recombinant schistosomula 21.7 kDa protein,” Arab Journal of Biotechnology, vol. 24, pp. 229–249, 2001. View at Google Scholar
  38. R. M. Cook, C. Carvalho-Queiroz, G. Wilding, and P. T. LoVerde, “Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage,” Infection and Immunity, vol. 72, no. 10, pp. 6112–6124, 2004. View at Publisher · View at Google Scholar · View at PubMed
  39. M. H. Romeih, H. M. Hassan, T. S. Shousha, and M. A. Saber, “Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine,” Acta Biochimica et Biophysica Sinica, vol. 40, no. 4, pp. 327–338, 2008. View at Publisher · View at Google Scholar
  40. W. Zhang, G. Ahmad, W. Torben, and A. A. Siddiqui, “Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse,” Parasite Immunology, vol. 32, no. 4, pp. 252–258, 2010. View at Publisher · View at Google Scholar · View at PubMed
  41. A. A. Da 'dara, P. J. Skelly, M. M. Wang, and D. A. Harn, “Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice,” Vaccine, vol. 20, no. 3-4, pp. 359–369, 2001. View at Publisher · View at Google Scholar
  42. A. A. Da 'dara, P. J. Skelly, M. Fatakdawala, S. Visovatti, E. Eriksson, and D. A. Harn, “Comparative efficacy of the Schistosoma mansoni nucleic acid vaccine, Sm23, following microseeding or gene gun delivery,” Parasite Immunology, vol. 24, no. 4, pp. 179–187, 2002. View at Publisher · View at Google Scholar
  43. H. M. Ahmed, M. H. Romeih, T. S. Abou Shousha et al., “DNA immunization with the gene encoding Sm21.7 protects mice against S. mansoni infections,” American Journal of Science, vol. 2, pp. 59–69, 2006. View at Google Scholar
  44. M. A. Saber and A. H. Hamid, “Molecular cloning, purification and characterization of Schistosoma mansoni fimbrin,” Arab Journal of Biotechnology, vol. 1, pp. 1–16, 1998. View at Google Scholar
  45. L. G. Pacifico, C. T. Fonseca, L. Chiari, and S. C. Oliveira, “Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine,” Immunobiology, vol. 211, no. 1-2, pp. 97–104, 2006. View at Publisher · View at Google Scholar · View at PubMed
  46. M. M. Mohamed, K. A. Shalaby, P. T. LoVerde, and A. M. Karim, “Characterization of Sm20.8, a member of a family of schistosome tegumental antigens,” Molecular and Biochemical Parasitology, vol. 96, no. 1-2, pp. 15–25, 1998. View at Publisher · View at Google Scholar
  47. L. Dupre, L. Kremer, I. Wolowczuk, G. Riveau, A. Capron, and C. Locht, “Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection,” Vaccine, vol. 19, no. 11-12, pp. 1373–1380, 2001. View at Publisher · View at Google Scholar
  48. L. P. Farias, C. A. Tararam, P. A. Miyasato et al., “Screening the Schistosoma mansoni transcriptome for genes differentially expressed in the schistosomulum stage in search for vaccine candidates,” Parasitology Research, vol. 108, pp. 1–13, 2010. View at Publisher · View at Google Scholar · View at PubMed
  49. J. M. Pinho, F. C. Cardoso, D. O. Lopes et al., “Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology,” Parasitology, vol. 137, no. 7, pp. 1079–1088, 2009. View at Publisher · View at Google Scholar · View at PubMed
  50. D. O. Lopes, L. F. Paiva, M. A. Martins et al., “Sm21.6 a novel EF-hand family protein member located on the surface of Schistosoma mansoni adult worm that failed to induce protection against challenge infection but reduced liver pathology,” Vaccine, vol. 27, no. 31, pp. 4127–4135, 2009. View at Publisher · View at Google Scholar · View at PubMed
  51. F. C. Cardoso, J. M. Pinho, V. Azevedo, and S. C. Oliveira, “Identification of a new Schistosoma mansoni membrane-bound protein through bioinformatic analysis,” Genetics and Molecular Research, vol. 5, no. 4, pp. 609–618, 2006. View at Google Scholar
  52. A. A. Siddiqui, Y. Zhou, R. B. Podesta et al., “Characterization of Ca2+-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoni,” Biochimica et Biophysica Acta, vol. 1181, no. 1, pp. 37–44, 1993. View at Publisher · View at Google Scholar
  53. R. E. Ridi and H. Tallima, “Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis,” Vaccine, vol. 27, no. 5, pp. 666–673, 2009. View at Publisher · View at Google Scholar · View at PubMed
  54. S. Hota-Mitchell, A. A. Siddiqui, G. A. Dekaban, J. Smith, C. Tognon, and R. B. Podesta, “Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain,” Vaccine, vol. 15, no. 15, pp. 1631–1640, 1997. View at Publisher · View at Google Scholar
  55. A. A. Siddiqui, T. Phillips, H. Charest et al., “Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation,” Vaccine, vol. 21, no. 21-22, pp. 2882–2889, 2003. View at Publisher · View at Google Scholar
  56. S. Y. Sauma and M. Strand, “Identification and characterization of glycosylphosphatidylinositol-linked Schistosoma mansoni adult worm immunogens,” Molecular and Biochemical Parasitology, vol. 38, no. 2, pp. 199–210, 1990. View at Publisher · View at Google Scholar
  57. S. Y. Sauma, T. M. Tanaka, and M. Strand, “Selective release of a glycosylphosphatidylinositol-anchored antigen from the surface of Schistosoma mansoni,” Molecular and Biochemical Parasitology, vol. 46, no. 1, pp. 73–80, 1991. View at Publisher · View at Google Scholar
  58. T. M. Hall, G. T. Joseph, and M. Strand, “Schistosoma mansoni: molecular cloning and sequencing of the 200-kDa chemotherapeutic target antigen,” Experimental Parasitology, vol. 80, no. 2, pp. 242–249, 1995. View at Publisher · View at Google Scholar · View at PubMed
  59. E. L. Racoosin, S. J. Davies, and E. J. Pearce, “Caveolae-like structures in the surface membrane of Schistosoma mansoni,” Molecular and Biochemical Parasitology, vol. 104, no. 2, pp. 285–297, 1999. View at Publisher · View at Google Scholar
  60. P. J. Brindley, M. Strand, A. P. Norden, and A. Sher, “Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens,” Molecular and Biochemical Parasitology, vol. 34, no. 2, pp. 99–108, 1989. View at Google Scholar
  61. Y. Wang and J. S. Morrow, “Identification and characterization of human SLP-2, a novel homologue of stomatin (band 7.2b) present in erythrocytes and other tissues,” The Journal of Biological Chemistry, vol. 275, no. 11, pp. 8062–8071, 2000. View at Publisher · View at Google Scholar
  62. P. Francis and Q. Bickle, “Cloning of a 21.7-kDa vaccine-dominant antigen gene of Schistosoma mansoni reveals an EF hand-like motif,” Molecular and Biochemical Parasitology, vol. 50, no. 2, pp. 215–224, 1992. View at Publisher · View at Google Scholar
  63. C. M. Fitzsimmons, R. McBeath, S. Joseph et al., “Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: molecular structure and patterns of in vivo exposure,” International Archives of Allergy and Immunology, vol. 142, no. 1, pp. 40–50, 2007. View at Publisher · View at Google Scholar · View at PubMed
  64. S. R. Reynolds, C. B. Shoemaker, and D. A. Harn, “T and B cell epitope mapping of SM23, an integral membrane protein of Schistosoma mansoni,” Journal of Immunology, vol. 149, no. 12, pp. 3995–4001, 1992. View at Google Scholar
  65. B. Koster and M. Strand, “Schistosoma mansoni: Sm23 is a transmembrane protein that also contains a glycosylphosphatidylinositol anchor,” Archives of Biochemistry and Biophysics, vol. 310, no. 1, pp. 108–117, 1994. View at Publisher · View at Google Scholar · View at PubMed
  66. H. Mei and P. T. LoVerde, “Schistosoma mansoni: the developmental regulation and immunolocalization of antioxidant enzymes,” Experimental Parasitology, vol. 86, no. 1, pp. 69–78, 1997. View at Publisher · View at Google Scholar · View at PubMed
  67. D. Grezel, M. Capron, J. M. Grzych, J. Fontaine, J. P. Lecocq, and A. Capron, “Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies,” European Journal of Immunology, vol. 23, no. 2, pp. 454–460, 1993. View at Google Scholar · View at Scopus
  68. R. J. Pierce, J. M. Balloul, J. M. Grzych et al., “GP38, P28-I and P28-II: candidates for a vaccine against schistosomiasis,” Memorias do Instituto Oswaldo Cruz, vol. 82, pp. 111–114, 1987. View at Google Scholar · View at Scopus
  69. C. B. Xu, C. Verwaerde, J. M. Grzych, J. Fontaine, and A. Capron, “A monoclonal antibody blocking the Schistosoma mansoni 28-kDa glutathione S-transferase activity reduces female worm fecundity and egg viability,” European Journal of Immunology, vol. 21, no. 8, pp. 1801–1807, 1991. View at Google Scholar · View at Scopus
  70. L. Kremer, G. Riveau, A. Baulard, A. Capron, and C. Locht, “Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase,” Journal of Immunology, vol. 156, no. 11, pp. 4309–4317, 1996. View at Google Scholar · View at Scopus
  71. N. Ivanoff, N. Phillips, A. M. Schacht, C. Heydari, A. Capron, and G. Riveau, “Mucosal vaccination against schistosomiasis using liposome-associated Sm 28 kDa glutathione S-transferase,” Vaccine, vol. 14, no. 12, pp. 1123–1131, 1996. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Dupre, O. Poulain-Godefroy, E. Ban et al., “Intradermal immunization of rats with plasmid DNA encoding schistosoma mansoni 28 kDa glutathione S-transferase,” Parasite Immunology, vol. 19, no. 11, pp. 505–513, 1997. View at Google Scholar · View at Scopus
  73. E. E. Comoy, A. Capron, and G. Thyphronitis, “Adjuvant is the major parameter influencing the isotype profiles generated during immunization with a protein antigen, the Schistosoma mansoni Sm28-GST,” Scandinavian Journal of Immunology, vol. 47, no. 5, pp. 444–452, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. J. B. Sun, N. Mielcarek, M. Lakew et al., “Intranasal administration of a Schistosoma mansoni glutathione S- transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice,” Journal of Immunology, vol. 163, no. 2, pp. 1045–1052, 1999. View at Google Scholar · View at Scopus
  75. L. Dupre, M. Herve, A. M. Schacht, A. Capron, and G. Riveau, “Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment,” Journal of Infectious Diseases, vol. 180, no. 2, pp. 454–463, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. A. Capron, G. Riveau, M. Capron, and F. Trottein, “Schistosomes: the road from host-parasite interactions to vaccines in clinical trials,” Trends in Parasitology, vol. 21, no. 3, pp. 143–149, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. T. Teixeira de Melo, J. Michel de Araujo, F. Do Valle Dure et al., “Immunization with newly transformed Schistosoma mansoni schistosomula tegument elicits tegument damage, reduction in egg and parasite burden,” Parasite Immunology, vol. 32, no. 11-12, pp. 749–759, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. J. R. Coura and R. S. Amaral, “Epidemiological and control aspects of schistosomiasis in Brazilian endemic areas,” Memorias do Instituto Oswaldo Cruz, vol. 99, no. 5, pp. 13–19, 2004. View at Google Scholar · View at Scopus
  79. C. A. Tararam, L. P. Farias, R. A. Wilson, and L. C. Leite, “Schistosoma mansoni Annexin 2: molecular characterization and immunolocalization,” Experimental Parasitology, vol. 126, no. 2, pp. 146–155, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. H. K. Rofatto, C. A. Tararam, W. C. Borges, R. A. Wilson, L. C. C. Leite, and L. P. Farias, “Characterization of phosphodiesterase-5 as a surface protein in the tegument of Schistosoma mansoni,” Molecular and Biochemical Parasitology, vol. 166, no. 1, pp. 32–41, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. G. Krautz-Peterson, S. Camargo, K. Huggel, F. Verrey, C. B. Shoemaker, and P. J. Skelly, “Amino acid transport in schistosomes: characterization of the permease heavy chain SPRM1hc,” Journal of Biological Chemistry, vol. 282, no. 30, pp. 21767–21775, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. Z. Faghiri, S. M. Camargo, K. Huggel et al., “The tegument of the human parasitic worm Schistosoma mansoni as an excretory organ: the surface aquaporin SmAQP is a lactate transporter,” Plos one, vol. 5, no. 5, Article ID e10451, 2010. View at Publisher · View at Google Scholar · View at PubMed
  83. Z. Faghiri and P. J. Skelly, “The role of tegumental aquaporin from the human parasitic worm, Schistosoma mansoni, in osmoregulation and drug uptake,” The FASEB Journal, vol. 23, no. 8, pp. 2780–2789, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. F. El-Shehabi, J. J. Vermeire, T. P. Yoshino, and P. Ribeiro, “Developmental expression analysis and immunolocalization of a biogenic amine receptor in Schistosoma mansoni,” Experimental Parasitology, vol. 122, no. 1, pp. 17–27, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. F. El-Shehabi and P. Ribeiro, “Histamine signalling in Schistosoma mansoni: immunolocalisation and characterisation of a new histamine-responsive receptor (SmGPR-2),” International Journal for Parasitology, vol. 40, no. 12, pp. 1395–1406, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. W. Yang, D. C. Jackson, Q. Zeng, and D. P. McManus, “Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice,” Vaccine, vol. 19, no. 1, pp. 103–113, 2000. View at Publisher · View at Google Scholar · View at Scopus